Antibiotics | Carbapenemase-producing E. coli Resistance, n (%) | Carbapenemase-producing K. pneumoniae Resistance, n (%) | ||||
---|---|---|---|---|---|---|
Hospital (n = 38) | Community (n = 53) | p-value | Hospital (n = 21) | Community (n = 25) | p-value | |
CHL | 03 (7.9%) | 24 (45.3%) | 0.0001 | 03 (14.3%) | 03 (12.0%) | 0.578 |
GEN | 19 (50.0%) | 34 (64.2%) | 0.128 | 18 (85.7%) | 06 (24.0%) | 0.0001 |
TET | 25 (65.8%) | 33 (62.3%) | 0.452 | 5 (23.8%) | 07 (28.0%) | 0.508 |
SXT | 30 (78.9%) | 29 (54.7%) | 0.025 | 17 (81.0%) | 12 (48.0%) | 0.032 |